Europe Heparin Market- Regional Analysis
Among country, U.K. is the fastest-growing segment in the Europe heparin market over the forecast period. According to an article published in Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions, on August 29, 2022, explained pretreatment with unfractionated heparin was associated with a reduction in coronary artery occlusion among patients with segment elevation myocardial infarction, with a number needed to treat (NNT) of 12, without increasing the risk of major in-hospital bleeding. Regarding mortality, a reduction was found with unfractionated heparin pretreatment, with an NNT of 94, but this effect was not robust over all sensitivity analyses and residual confounding cannot be excluded.
Europe Heparin Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients